Search Results

CSL Behring develops, produces, and markets plasma derivatives for the indication and therapy areas of anti-D prophylaxis, coagulation disorders, hepatitis prophylaxis, hereditary angioedema (HAE), hemophilia, immune deficiencies and intensive care medicine.

https://www.cslbehring.de/en-us/products/product-overview

CSL Behring offers biotherapeutics in the areas of hemophilia, immunodeficiencies, hereditary angioedema (HAE), fibrinogen deficiency, Alpha-1-antitrypsin deficiency and other rare diseases. Furthermore, for the prophylaxis of rhesus incompatibility in pregnancy, to reduce the risk of bleeding during emergency interventions as well as during planned operations.

https://www.cslbehring.de/en-us/products

If you have experienced an adverse drug reaction to a CSL Behring product, we recommend that you consult with your doctor, pharmacist, or nurse.

https://www.cslbehring.de/en-us/report-an-adverse-drug-reaction

Your questions and concerns are important to us. You can reach us via these channels for medical questions about products, their effects or application or for product orders.

https://www.cslbehring.de/en-us/contact-us

CSL Behring complies with all government regulations set forth by the countries in which we manufacture and market products.

https://www.cslbehring.de/en-us/products/regulatory-compliance

Information on the terms and conditions of use of the CSL Behring Germany website.

https://www.cslbehring.de/en-us/terms-of-use

Employees of CSL Behring are looking forward to a promising future.

https://www.cslbehring.de/en-us/careers/career-profiles

We are a leader in the development and introduction of innovative therapies that can treat rare and serious diseases.

https://www.cslbehring.de/en-us/our-company/leading-the-way

We are proud to serve the serious and rare diseases community with treatments and therapies in numerous therapeutic areas.

https://www.cslbehring.de/en-us/patients/diseases

On-site pilot plant A separate pilot plant for plasma products provides conditions for clinical-scale research and production-scale development.

https://www.cslbehring.de/-/media/cslb-germany2/global-csl-behring/csl-big/m600-innovation-hub/m600_brochure_july-2026.pdf